LUPIN PHARMACEUTICALS INC.

Lobbying client · Maryland · filed 2025 to 2025

Pharmaceutical manufacturer

$320,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (63988), not by name.

Firms hired 1

BALLARD PARTNERS $320,000 5 filings

Reported by year 1 year

2025 $320,000 5 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

U.S. Trade Representative (USTR) 3
White House Office 3
Commerce, Dept of (DOC) 2

Recent filings 6 total

4TY

BALLARD PARTNERS

4th Quarter (Oct 1 - Dec 31) 2025 · $80,000 income · posted Apr 20, 2026

View → Q4Y

BALLARD PARTNERS Amended

4th Quarter (Oct 1 - Dec 31) 2025 · $80,000 income · posted Jan 14, 2026

View → Q3

BALLARD PARTNERS

3rd Quarter (July 1 - Sep 30) 2025 · $80,000 income · posted Oct 16, 2025

View → Q2

BALLARD PARTNERS

2nd Quarter (Apr 1 - June 30) 2025 · $80,000 income · posted Jul 16, 2025

View → Q1

BALLARD PARTNERS

1st Quarter (Jan 1 - Mar 31) 2025 · $80,000 income · posted Apr 16, 2025

View → RR

BALLARD PARTNERS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Feb 4, 2025

View →

Foreign entities disclosed 1

LUPIN LTD. India named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.